X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

期刊標題檢索 EUR J DRUG META 最新評論: This magazine does not have any article processing charges. Submission... (2022-01-16)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS]您好,您是該頁面的第 18668 位訪客。

期刊簡介
期刊名稱EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
LetPub Score
5.4
50 ratings
Rate

Reputation
6.4

Influence
3.7

Speed
9.5

期刊簡稱EUR J DRUG METAB PH
ISSN0378-7966
E-ISSN2107-0180
h-index34
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.700.4620.596
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q2136 / 272
Category: Medicine
Subcategory: Pharmacology
Q3185 / 313

自引率 (2023-2024)5.30%自引率趨勢
掲載範囲
Hepatology International is a peer-reviewed journal featuring articles written by clinicians, clinical researchers and basic scientists is dedicated to research and patient care issues in hepatology. This journal focuses mainly on new and emerging diagnostic and treatment options, protocols and molecular and cellular basis of disease pathogenesis, new technologies, in liver and biliary sciences.

Hepatology International publishes original research articles related to clinical care and basic research; review articles; consensus guidelines for diagnosis and treatment; invited editorials, and controversies in contemporary issues. The journal does not publish case reports.
官方網站https://www.springer.com/13318
在線稿件提交https://www.editorialmanager.com/ejdr
開放訪問No
出版商Springer International Publishing
主題領域医学
出版國/地區SWITZERLAND
發行頻率四半期刊行
創刊年1976
每年文章數57每年文章數趨勢
黃金OA百分比27.37%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ3231/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0378-7966%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498668
    PHYTOMEDICINE343779
    LIFE SCIENCES291012
    PHARMACOLOGICAL RESEARCH244009
    International Journal of Pharmaceutics242769
    European Journal of Pharmacology204566
    BIOCHEMICAL PHARMACOLOGY203069
    JOURNAL OF NATURAL PRODUCTS196876
    BRITISH JOURNAL OF PHARMACOLOGY165451
    MOLECULAR PHARMACEUTICS162992
  •  

    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS] 的評論撰寫評論
作者: 北海幼霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-16 19:19:23 評論於
This magazine does not have any article processing charges. Submissions are divided into OA (with an approximate APC of 20,000 RMB) and non-OA (we mainly choose non-OA, with a slightly higher chance of rejection, but no APC
(0) 讚! | 北海幼霜

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:24:34 評論於
Thank you to the editors and reviewers; we are working hard to make revisions, but experiments take time; confirming the necessary time
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:39:30 評論於
1. Subject: Submission Section, Article Title, Pen Name. Content: The full content of the article.
2. Author information is included after the main text. Author information includes: your actual contact address, postal code, name, email address, landline phone number, mobile phone number, QQ number (indicate QQ name), and any other contact information you deem necessary to provide (such as a brief bio
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 21:18:53 評論於
What aspects should be paid attention to in the letters sent by journals?
(0) 讚! | 陶宜三岁啦

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 10:37:26 評論於
How to write a letter asking for an extension?
(0) 讚! | 上清雨真

作者: 北海幼霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-17 10:58:41 評論於
Review speed: 2.0 | Submission hit rate: 50.0
Experience sharing: Submitted on 08.01, accepted on 11.16. Fast speed, high editing efficiency, and very professional reviewer comments. Our research content is "metabolic enzymes + pharmacokinetics + pharmacodynamics". Revisions were made twice, but no grammar issues were mentioned. Reviewers focused on the experimental standards, data processing, and logical reasoning of the paper itself. 
Phase one: 
2021.08.01 New submission 
2021.08.05 Under review Editor review 
2021.08.09 Reviewers assigned Assigned reviewers 
2021.08.17 Under review Review 
2021.09.19 Major Revise Major revision (two reviewers, ten opinions) 
Phase two: 
2021.10.08 Revision Submitted 
2021.10.09 Editor Assigned Assigned editor 
2021.10.10 Reviewers Assigned —— Under review Review by reviewers 
2021.11.01 Major Revise Major revision (one reviewer, 1 opinion) 
Received: 
2021.11.10 Revision Submitted 
2021.11.14 Editor Decision - Accept 
2021.11.16 Final Decision Accept
(0) 讚! | 北海幼霜

作者: 五毒思柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-07-09 20:28:26 評論於
Is there a layout fee?
(0) 讚! | 五毒思柔

作者: 东京语风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-21 10:35:38 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: I submitted an article on bioequivalence, and it took about three months from submission to acceptance. The first review came back with a lot of comments, but they were very fair. There were four reviewers for the first review and three for the second review, with fewer comments. After the second round of revisions, I was accepted in about 4 days
(0) 讚! | 东京语风

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 19:46:43 評論於
It's a bit bleak, couldn't even keep that 1.5 points, how to go on?
(0) 讚! | 凌霄高洁

作者: 猫巷少女杉月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 08:17:09 評論於
Do we need to pay for the review fee? Is the page fee expensive? Thank you!
(0) 讚! | 猫巷少女杉月

作者: 咏春承嗣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-08 22:26:40 評論於
Pharmacokinetics-related articles, received feedback for revision after one month. Although the submission was rejected, the feedback was comprehensive and helpful for learning
(0) 讚! | 咏春承嗣

作者: sj_zrf@126.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2017-06-08 21:48:24 評論於
pharmacokinetic related article, 1 month gave a revised opinion, although rejectedThe revised comments were given in place, and the
(0) 讚! | sj_zrf@126.com

作者: 瑞新小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-07-04 22:46:20 評論於
Just received a preclinical pharmacokinetic article on animal medicine on June 30, 2016. The initial draft was submitted on May 13, 2016 and the review comments were received on June 17, 2016. Made minor revisions to 33 areas, some places where English was not fluent, some details that needed clarification, and some topics that needed discussion. Responded to the comments on June 22, and was accepted on June 30. Overall, it went smoothly, with not very high requirements for technical innovation (not necessarily using the most advanced technology for research), sufficient amount of data, and clear purpose, methods, and results. Being able to explain some issues and having some reference value is enough. I am researching a new drug
(0) 讚! | 瑞新小仙女

作者: 暴风长志


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-03-26 20:19:46 評論於
Review Speed: 2.0 Experience sharing: Submitted a pharmacokinetics article. Received revisions within 2 months, with lots of detailed suggestions. They said my writing was not up to par. Then did a major revision, only to be rejected 4 days later. They said the writing didn't improve. The topic didn't fit their requirements. I wanted to say, why didn't you say it didn't fit earlier
(0) 讚! | 暴风长志

作者: yedou_xuaner@163.com


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2015-03-26 13:53:31 評論於
2 months to first decision. Many detailed comments. You need to meticulously address the reviewer concerns.

(0) 讚! | yedou_xuaner@163.com

作者: 幽花连成


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-03-26 13:27:01 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Experience sharing: Submitted an article on pharmacokinetics. Received feedback within 2 months, with a lot of detailed suggestions. They said my writing was not up to standard. Then I made major revisions, and 4 days later, received rejection... they said the writing had not improved. The theme did not meet their requirements, etc. I wanted to say, why didn't you say it didn't meet the requirements earlier?
(0) 讚! | 幽花连成

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-08-21 18:09:00 評論於
Journal Homepage URL: http://www.springer.com/biomed/p ... ience/journal/13318
(0) 讚! | 匿名

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 18:26:06 評論於
Research focus: Metabolism
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 08:33:06 評論於
Biased Research Direction: Metabolism
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*